Belarus faces HIV crisis because of too few blood tests
This article was originally published in Clinica
The rate of HIV and tuberculosis infection in Belarus is spiralling out of control, mainly because the lack of money in many regions has meant that there are no blood tests. Some 3,000 people were infected with AIDS in Belarus in 2000 and officials say they must act quickly to avoid these becoming enormous public health problems, as in neighbouring Russia.
You may also be interested in...
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.